EUVIMEDEUVIMED entdecken
Crossref

PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy

Jungsup Byun, Nora Jee-Young Park, Ghilsuk Yoon, Min Kyu Kang, Hye Jin Kim, Soo Yeun Park, Jun Seok Park, Gyu Seog Choi, Jin Ho Baek, Jong Gwang Kim, An Na Seo

Anticancer Research · 2023

DOI: 10.21873/anticanres.16300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Jungsup Byun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Rectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyRectal NeoplasmsHumansPrognosisRectumDisease-Free SurvivalClass I Phosphatidylinositol 3-KinasesChemoradiotherapyRetrospective StudiesNeoplasm Staging

Stichwörter der Autor:innen

PIK3CARectal cancermutationneoadjuvant chemoradiotherapyprognosis

Substanzen

Class I Phosphatidylinositol 3-KinasesPIK3CA protein, human

Autor:innen und Institutionen

  • Department of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
  • Department of Radiation Oncology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
  • Department of Surgery, Colorectal Cancer Center, School of Medicine, Kyungpook National University Chilgok Hospital, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Hematology/Oncology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
  • Department of Pathology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea; san_0729@naver.com.

Zitieren

APA

Byun, J., Park, N. J., Yoon, G., Kang, M. K., Kim, H. J., Park, S. Y., Park, J. S., Choi, G. S., Baek, J. H., Kim, J. G., & Seo, A. N. (2023). PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy. Anticancer Research. https://doi.org/10.21873/anticanres.16300

Vancouver

Byun J, Park NJ, Yoon G, Kang MK, Kim HJ, Park SY, et al. PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy. Anticancer Research. 2023. doi:10.21873/anticanres.16300

BibTeX
@article{Byun2023,
  author = {Byun, Jungsup and Park, Nora Jee-Young and Yoon, Ghilsuk and Kang, Min Kyu and Kim, Hye Jin and Park, Soo Yeun and Park, Jun Seok and Choi, Gyu Seog and Baek, Jin Ho and Kim, Jong Gwang and Seo, An Na},
  title = {PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16300}
}
Kostenlos starten →